Objective: This retrospective study aimed to determine the predictive factors for the efficacy of pelvic arterial embolization for postpartum hemorrhage. Materials and methods: Twenty-one patients who underwent pelvic arterial embolization for postpartum hemorrhage of >1000 mL between September 2006 and September 2011 were enrolled in this study. The patients were divided into two subgroups according to the blood loss and time from the end of pelvic arterial embolization to complete hemostasis: good-response (16 patients) and poor-response groups (5 patients). The following predictive factors were compared between the groups: (1) patient characteristics; (2) blood loss; (3) time between delivery (or onset of bleeding) and pelvic arterial embolization; (4) obstetrical disseminated intravascular coagulation score comprising clinical background, clinical signs, and laboratory data; (5) individual disseminated intravascular coagulation score; (6) shock index; and (7) laboratory data including platelet count, prothrombin time-international normalized ratio, fibrinogen, fibrin degradation products, and antithrombin-III at the time of pelvic arterial embolization. Results: In the poor-response group, the obstetrical and individual disseminated intravascular coagulation scores and prothrombin time-international normalized ratio were higher than those in the goodresponse group (p < 0.05). Platelet count, fibrinogen, and fibrin degradation products were lower than those in the good-response group (p < 0.05). All obstetrical disseminated intravascular coagulation scores in the poor-response group were >9 points. Conclusion: The efficacy of pelvic arterial embolization is related to the presence or absence of coagulation disorders. When the obstetrical disseminated intravascular coagulation score is high (>9 points), the efficacy may be poor.
Introduction
Postpartum hemorrhage (PPH) is still one of the leading causes of maternal death in developed countries [1À3] . Over the past few decades, pelvic arterial embolization (PAE) has become a reliable and safe alternative treatment method for PPH when uncontrollable hemorrhage occurs with conventional procedures such as manual and surgical compression of the uterus, local and systemic administration of uterotonic agents, and suturing of bleeding sites of the uterus and birth canal [4À6] . The success rate of PAE for PPH is high (79e95%) with complications rates from 3% to 12% [7À9] . PAE has an advantage over ligation of hypogastric and uterine arteries and hysterectomy for a variety of reasons. PAE can possibly control hemorrhage in regions that are not supplied by surgically ligated arteries or sites in which collateral circulation exists. This technique can also be beneficial for patients with coagulopathy in whom surgical interventions are contraindicated. Furthermore, it preserves the reproductive function of patients, including the ability to become pregnant in the future.
When treating patients with PPH, it is vital to know the efficacy of PAE in advance to determine the best strategy with which to control hemorrhage that is refractory to conventional procedures. Which patients are good candidates for PAE and under which conditions is it appropriate to intervene? To the best of our knowledge, there have been three reports regarding the predictive factors of PAE for PPH; however, the criteria for success of PAE and the indications for repeat PAE were ill-defined [7, 8, 10] . In this study, patients with PPH who underwent PAE in our three institutes were retrospectively reviewed. Based on well-defined criteria for hemostasis after PAE, the aim was to determine the predictive factors for the efficacy of PAE.
Materials and methods
Between September 2006 and September 2011, a total of 6772 births were recorded at Fukuoka University Hospital, Fukuoka Tokushukai Hospital, and Yamaguchi Red Cross Hospital, Fukuoka, 
Japan. Among 1147 Japanese women who had PPH of >1000 mL during this period, 23 underwent PAE for PPH. After excluding two patients for whom complete medical records were not obtained, 21 patients were subjected to subsequent analysis. This study was approved by the institutional review boards of the individual hospitals.
The patients' characteristics are summarized in Table 1 . The median maternal age was 32.0 years (range, 25e39 years). Four patients were primiparous. Two patients had medical complications: one had mixed connective tissue disease, and one had focal glomerulonephritis. Seven patients had obstetrical complications: three had abruptio placentae, one had preeclampsia, one had preeclampsia and a low-lying placenta, one had gestational hypertension, and one had placenta previa. The median gestational age at delivery was 39.0 (range, 28e41) weeks. Twelve patients delivered transvaginally, and the remaining nine patients underwent Cesarean section or hysterectomy. The causes of PPH included 12 cases of uterine atony, two cases of retained placenta, two cases of rupture of a pseudoaneurysm of the uterus or birth canal, one case of placenta accreta, one case of coagulopathy, and three cases of unknown cause. Eleven patients were referred from other hospitals for the treatment of PPH.
The policy for the treatment of PPH refractory to conventional procedures is that PAE is the first-choice therapy unless the hemodynamic state of the patient is critically unstable. No patients underwent ligation of the hypogastric and/or uterine arteries or hysterectomy prior to considering PAE. Supportive therapies for blood loss and treatment for coagulopathy were performed when necessary prior to, during, and after PAE. Twenty patients had a blood transfusion as indicated by the guidelines proposed by the Japan Society of Obstetrics and Gynecology [11] . Treatment for disseminated intravascular coagulation (DIC) was started when the total obstetrical DIC score, originally proposed by Maki et al [12] ( Table 2) , was !8 points. PAE was performed in 16 patients for primary PPH occurring within the first 24 hours after delivery and in the remaining five patients for secondary PPH that occurred >24 hours but <6 weeks from delivery. PAE was performed by well-trained interventional radiologists. The PAE methods were chosen on a case-by-case basis and are summarized in Table 3 . The median time for PAE was 75 (range, 40e220) minutes. Extravasation occurred in seven patients. The internal iliac arteries, uterine arteries, or peripheral branches of the uterine arteries were embolized unilaterally in three patients and bilaterally in 18 patients. Regarding the embolization agents, absorbable gelatin sponges were used in 17 patients, and absorbable gelatin sponges and platinum coils were used in four patients. Only one patient (Case 4) underwent repeat PAE.
The efficacy of PAE was evaluated according to the blood loss and time interval in hours from the end of PAE to complete hemostasis. Complete hemostasis was defined as blood loss of <10 mL per hour. The patients were divided into two subgroups: the goodresponse group (16 patients) and poor-response group (five patients). In the former group, the blood loss was 0À240 mL (median, 8 mL), and the time interval until complete hemostasis was 1À6 hours (median, 1.5 hours). In the latter group, the blood loss was 513À2430 mL (median, 1053 mL), and the time interval until complete hemostasis was 9À18 hours (median, 9.0 hours; Fig. 1 ).
The following predictive factors related to the efficacy of PAE for PPH between the good-and poor-response groups were compared: Table 1 . Good ¼ good-response group; Poor ¼ poor-response group. In Case 4, the blood loss and time interval was calculated from the first embolization.
(1) patient characteristics including maternal age, parity, medical and obstetrical complications, gestational age at delivery, and delivery mode; (2) blood loss; (3) time interval from delivery (or onset of bleeding for secondary PPH) to PAE; (4) shock index (SI; i.e., pulse rate divided by systolic blood pressure); (5) total and individual obstetrical DIC scores; and (6) laboratory data as mentioned below regarding coagulation and fibrinolysis at PAE or the most recent time prior to PAE. The total obstetrical DIC score comprised the three individual scorings representing the clinical background, clinical signs, and laboratory data regarding coagulation and fibrinolysis. The laboratory data included platelet count, prothrombin time-international normalized ratio (PT-INR), fibrinogen, fibrin degradation products (FDP), and anti-thrombin-III (AT-III). When the data were beyond or less than the detection limits, these limits were indicated as the representative values. The statistical analyses were performed using the Chi-square test and MannÀWhitney test, and statistical significance was set at p < 0.05.
Results
There were no differences in maternal age, parity, gestational age at delivery, or rate of Cesarean section between the groups. There was one patient with mixed connective disease in the poorresponse group and one patient with focal glomerulonephritis in the good-response group (Table 1 ). All five patients in the poorresponse group had obstetrical complications: abruptio placentae (3 patients), placenta previa (1 patient), and low-lying placenta and preeclampsia (1 patient). By contrast, among the patients in the good-response group, only two had obstetrical complications: gestational hypertension (1 patient) and preeclampsia (1 patient).
There was no difference in the blood loss prior to PAE in the good-versus poor-response groups (2665 ± 1400 mL vs. 3152 ± 1390 mL, respectively), the time interval from delivery (or onset of bleeding) to PAE (6.5 ± 2.9 hours vs. 5.4 ± 3.1 hours, respectively; Fig. 2, Table 4 ), and the shock index at PAE (0.9 ± 0.4 vs. 1.2 ± 0.5, respectively; Fig. 3, Table 4 ). The total obstetrical DIC scores of the patients in the poorresponse group were higher than those of the patients in the good-response group (p ¼ 0.001; Fig. 4 ). All patients in the poorresponse group had total obstetrical DIC scores of >9 points. The obstetrical DIC scores for clinical background, clinical signs, and laboratory data of the patients in the poor-response group were higher than those of the patients in the good-response group (p ¼ 0.004, p ¼ 0.027, and p ¼ 0.003, respectively). The platelet count and fibrinogen level of the patients in the poor-response group were lower than those of the patients in the good-response group (p ¼ 0.005 and p ¼ 0.020, respectively; Fig. 5 ). The PT-INR and FDP concentration of the patients in the poorresponse group were higher than those of the patients in the good-response group (p ¼ 0.017 and p ¼ 0.033, respectively). There was no difference in the AT-III activity between the groups.
Discussion
PPH refractory to conventional procedures was well controlled by PAE alone, with a single PAE success rate of 95.2% and a secondattempt PAE success rate of 4.8%; these outcomes are similar to those previously reported [7, 9, 13] . In this study, the efficacy of PAE for PPH was evaluated by the blood loss and time interval from the end of PAE to complete hemostasis, and the patients were clearly divided into good-and poor-response groups. The only predictive factor for the efficacy of PAE was the presence or absence of coagulopathy; i.e., high obstetrical DIC scores and abnormal levels of biomarkers including platelet count, PT-INR, fibrinogen, and FDP. All five patients in the poor-response group had either placental abruption or abnormal placentation, which are associated with a high risk of inducing coagulopathy.
There have been three reports concerning the predictive factors for PAE failure or the requirement for repeat PAE within 24 hours after the first PAE [7, 8, 10] . The risk factors were being primiparous, the presence of a coagulation disorder, extravasation, and an anatomical variant of the uterine arterial vasculature. Our results were partially compatible with these results. In this study, it was aimed to determine the predictive factors prior to PAE, and the factors that were obtained during PAE were excluded. There were no differences in terms of extravasation between the poor-and goodresponse groups [40.0% (2/5) vs. 31.3% (5/16), respectively]. No patients showed any anatomical variants of the uterine vasculature.
The remaining problems concern how to treat patients with a poor response to improve the efficacy of PAE. There were no differences in blood loss and time interval from delivery (or onset of bleeding) to PAE between the groups. However, in Case 3, which was referred from another hospital, 11 hours were required before PAE could deteriorate the coagulopathy; this case may have had a better outcome if the patient had been transferred in a timely manner and PAE had been performed earlier. When timely PAE is not available, prompt correction of any coagulopathies is necessary prior to PAE. The PAE procedures were performed at the discretion of each interventional radiologist. Two of the five patients in the poor-response group developed extravasation (Cases 2 and 5); only the ipsilateral artery was embolized. Complete hemostasis was confirmed during PAE; however, the collateral circulation from the contralateral or ovarian arteries may play a role in the development of hemorrhage after PAE. Another factor to be considered is the indication for repeat PAE. There was no clear criteria for repeat PAE. A second PAE was performed in Case 4 because substantial bleeding continued after the first PAE. Some authors recommend that repeat PAE is effective for uncontrollable bleeding after the first PAE prior to performing hysterectomy as a last resort [8, 10] . However, in repeat PAE, more intensive embolization may be necessary, which may lead to profound tissue damage later [14] . In fact, in Case 4, a hysterectomy was performed 82 days after PAE because of massive necrosis of the myometrial tissues. The balance between hemostasis by repeat PAE and potential complications should be considered, and this issue will be clarified in a further study.
Limitations of this study are its retrospective nature and inclusion of a small number of patients, yielding low statistical power. In addition, the results were biased because the clinical backgrounds and indications for PAE in this study differ from those of other reports. However, the results confirm that PAE is a safe alternative method to current surgical procedures for uncontrollable postpartum bleeding if the candidate is carefully chosen. These findings will provide informative feedback to obstetricians who plan to implement this technique in their clinical setting.
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